Special Issue "In Vivo Biomarkers for Immunotherapy Efficacy in Brain Tumours"
Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 7511
Interests: magnetic resonance spectroscopy; imaging biomarkers; preclinical tumour models; MR contrast agents; brain tumours; magnetic resonance imaging
Immunotherapy, in a broad sense, is gaining ground in cancer treatment and recent literature suggests that brain tumours could also benefit from such strategies. However, we still lack early in vivo biomarkers of successful immunotherapy or, in other words, biomarkers signaling effective immune system recruitment and action against tumours. The well-known pseudoprogression and pseudoresponse phenomena can lead to a misinterpretation at follow-up of the in vivo response to therapy in brain tumours. Moreover, since repeated biopsy is not feasible in human patients and not all patients will benefit from these therapies, knowing in advance whether an immunotherapy is properly recruiting the immune system or not would be of great benefit to patient management. In this Special Issue, we invite researchers to submit original research articles or reviews covering different aspects of the development, validation, and evaluation of in vivo biomarkers of immunotherapy. Potential topics include, but are not limited to imaging biomarkers based on MR approaches or PET; biomarker validation; liquid biopsies; preclinical studies that unravel cellular/molecular aspects of the response to immunotherapy.Prof. Dr. Ana Paula Candiota
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.